Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 7, 2007, Pages 822-828

  Ruzzo, Annamaria ^a   Canestrari, Emanuele ^a   Maltese, Paolo ^a   Pizzagalli, Francesca ^a   Graziano, Francesco ^b   Santini, Daniele ^c   Catalano, Vincenzo ^d   Ficarelli, Rita ^e   Mari, Davide ^f   Bisonni, Renato ^g   Giordani, Paolo ^d   Giustini, Lucio ^g   Lippe, Paolo ^g   Silva, Rosarita ^f   Mattioli, Rodolfo ^h   Torresi, Umberto ⁱ   Latini, Luciano ⁱ   Magnani, Mauro ^a  

^a UNIVERSITY OF URBINO   (Italy)

^b Hospital of Urbino   (Italy)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^d SAN SALVATORE HOSPITAL   (Italy)

^e Ospedale Civile di Senigallia   (Italy)

^f Hospital of Fabriano   (Italy)

^g Hospital of Fermo   (Italy)

^h Fano Hospital   (Italy)

ⁱ Macerata Hospital   (Italy)

Author keywords

Diffuse gastric cancer; DNA repair; GSTM1; GSTP1; GSTT1; Polymorphisms

Indexed keywords

EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; DNA REPAIR; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HELICOBACTER PYLORI; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH CANCER; XENOBIOTIC METABOLISM;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DNA REPAIR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ITALY; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; STOMACH NEOPLASMS; XENOBIOTICS;

HELICOBACTER PYLORI;

EID: 34447274966     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2007.143     Document Type: Article

References (66)

1. Vecchia C, Franceschi S. Nutrition and gastric cancer. Can J Gastroenterol 2000;14(Suppl D):51D-4D.
2. Stracci F, Moffa IF, Montefusco C, Minelli L, Falsettini E, La Rosa F. Trends in gastric cancer incidence, mortality and survival in the Umbria region of Italy, 1978-82 and 1994-99. Ann Ig 2004;16:665-72.
3. Maltoni C, Cormentano P, Colantoni P, Fusco E, Lenzi M, Kalogeropoulos T, et al. Report of the cancer registry of USL 5 of Urbino Monuzzi, vol 4. Bologna: USL 5, 1992:48-51.
4. Lauren P. The two histological main types of gastric carcinoma. Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
5. Lin W, Kao HW, Robinson D, Kung HJ, Wu CW, Chen HC. Tyrosine kinases and gastric cancer [review]. Oncogene 2000;19:5680-9.
6. Wu CW, Chi CW, Lin WC. Gastric cancer: prognostic and diagnostic advances. Expert Rev Mol Med 2002; 2002:1-12.
7. Madhusudan S, Middleton MR. The emerging role of DNA repair proteins as predictive, prognostic and therapeutic targets in cancer. Cancer Treat Rev 2005;31:603-17.
8. Clarkson SG, Wood RD. Polymorphisms in the human XPD (ERCC2) gene, DNA repair capacity and cancer susceptibility: an appraisal. DNA Repair (Amst) 2005;4:1068-74.
9. Cleaver JE. Cancer in xeroderma pigmentosum and related disorders of DNA repair. Nat Rev Cancer 2005;5:564-73.
10. Chow TY, Choudhury SA. DNA repair protein: endoexonuclease as a new frontier in cancer therapy. Future Oncol 2005;1:265-71.
11. Mohrenweiser HW. Genetic variation and exposure related risk estimation: will toxicology enter a new era? DNA repair and cancer as a paradigm. Toxicol Pathol 2004; 32(Suppl 1):136-45.
12. Jiricny J, Marra G. DNA repair defects in colon cancer. Curr Opin Genet Dev 2003;13:61-9.
13. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1513-30.
14. Evans E, Moggs JG, Hwang JR, Egly JM, Wood RD. Mechanism of open complex and dual incision formation by human nucleotide excision repair factors. EMBO J 1997;16:6559-73.
15. Lunn RM, Helzlsouer KJ, Parshad R, Umbach DM, Harris EL, Sanford KK, et al. XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis 2000;21:551-5.
16. Tang D, Cho S, Rundle A, Chen S, Phillips D, Zhou J, et al. Polymorphisms in the DNA repair enzyme XPD are associated with increased levels of PAH-DNA adducts in a case-control study of breast cancer. Breast Cancer Res Treat 2002;75:159-66.
17. Tsuchiya N, Mishina M, Narita S, Kumazawa T, Inoue T, Horikawa Y, et al. Association of XRCC1 gene polymorphisms with the susceptibility and chromosomal aberration of testicular germ cell tumors. Int J Oncol 2006; 28:1217-23.
18. Tebbs RS, Zhao Y, Tucker JD, Scheerer JB, Siciliano MJ, Hwang M, et al. Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNA repair gene. Proc Natl Acad Sci USA 1995;92:6354-8.
19. Thompson LH. Strategies for cloning mammalian DNA repair genes. Methods Mol Biol 1999;113:57-85.
20. Pierce AJ, Johnson RD, Thompson LH, Jasin M. XRCC3 promotes homology-directed repair of DNA damage in mammalian cells. Genes Dev 1999;13:2633-8.
21. Butkiewicz D, Rusin M, Enewold L, Shields PG, Chorazy M, Harris CC. Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis, 2001;22:593-7.
22. Matullo G, Guarrera S, Carturan S, Peluso M, Malaveille C, Davico L, et al. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer 2001;92:562-7.
23. Abdel-Rahman SZ, El-Zein RA. The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. Cancer Lett 2000; 159:63-71.
24. Park DJ, Zhang W, Stoehlmacher J, Tsao-Wei D, Groshen S, Gil J, et al. ERCC1 gene polymorphism as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy. Clin Adv Hematol Oncol 2003;1:162-6.
25. Leclerc D, Campeau E, Goyette P, Adjalla CE, Christensen B, Ross M, et al. Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Hum Mol Genet 1996;5:1867-74.
26. Crocetti E, Paci E, Miccinesi G, Costantini AS, Zappa M. Time trends in cancer incidence and mortality in central Italy. Eur J Cancer Prev 2002;11:387-95.
27. Harmon DL, Woodside JV, Yarnell JW, McMaster D, Young IS, McCrum EE, et al. The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. Q J Med 1996;89:571-7.
28. Persson I, Johansson I, Lou YC, Yue QY, Duan LS, Bertilsson L, et al. Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients. Int J Cancer 1999;81:325-9.
29. Kocabas NA, Sardas S, Karakaya AE. Polymorphisms related to estrogen and xenobiotic metabolism in healthy Turkish women. Arch Med Res 2005;36:19-23.
30. Harries LW, Stubbins MJ, Forman D, Howard GC, Wolf CR. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997;18:641-4.
31. Ketterer B. Glutathione S-transferases and prevention of cellular free radical damage. Free Radic Res 1998;28:647-58.
32. Brockmoller J, Cascorbi I, Kerb R, Sachse C, Roots I. Polymorphisms in xenobiotic conjugation and disease predisposition. Toxicol Lett 1998;102-103:173-83.
33. Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, et al. Metabolic gene polymorphism fre quencies in control populations. Cancer Epidemiol Biomarkers Prev 2001;10:1239-48.
34. de Bruin WC, Wagenmans MJ, Board PG, Peters WH. Expression of glutathione S-transferase theta class isoenzymes in human colorectal and gastric cancers. Carcinogenesis 1999;20:1453-7.
35. Savas S, Kim DY, Ahmad MF, Shariff M, Ozcelik H. Identifying functional genetic variants in DNA repair pathway using protein conservation analysis. Cancer Epidemiol Biomarkers Prev 2004;13:801-7.
36. Araujo FD, Pierce AJ, Stark JM, Jasin M. Variant XRCC3 implicated in cancer is functional in homology-directed repair of double-strand breaks. Oncogene 2002;21:4176-80.
37. Watson MA, Stewart RK, Smith GB, Massey TE, Bell DA. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998;19:275-80.
38. Arand M, Muhlbauer R, Hengstler J, Jager E, Fuchs J, Winkler L, et al. A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal Biochem 1996;236:184-6.
39. Habib EE, Aziz M, Kotb M. Genetic polymorphism of folate and methionine metabolizing enzymes and their susceptibility to malignant lymphoma. J Egypt Natl Cancer Inst 2005;17:184-92.
40. Ma J, Stampfer MJ, Christensen B, Giovannucci E, Hunter DJ, Chen J, et al. A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 1999;8:825-9.
41. Saadat M. Genetic polymorphisms of glutathione Stransferase T1 (GSTT1) and susceptibility to gastric cancer: a meta-analysis. Cancer Sci 2006;97:505-9.
42. Ulrich CM, Curtin K, Potter JD, Bigler J, Caan B, Slattery ML. Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 2005;14:2509-16.
43. McIlwain CC, Townsend DM, Tew KD. Glutathione Stransferase polymorphisms: cancer incidence and therapy. Oncogene 2006;25:1639-48.
44. Parl FF. Glutathione S-transferase genotypes and cancer risk. Cancer Lett 2005;221:123-9.
45. Efferth T, Volm M. Pharmacogenetics for individualized cancer chemotherapy. Pharmacol Ther 2005;107:155-76.
46. Ruzzo A, Graziano F, Kawakami K, Watanabe G, Santini D, Catalano V, et al. Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy. J Clin Oncol 2006; 24:1883-91.
47. Sturgis EM, Castillo EJ, Li L, Zheng R, Eicher SA, Clayman GL, et al. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 1999;20:2125-9.
48. Xing D, Qi J, Miao X, Lu W, Tan W, Lin D. Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population. Int J Cancer 2002; 100:600-5.
49. Duell EJ, Holly EA, Bracci PM, Wiencke JK, Kelsey KT. A population-based study of the Arg399Gln polymorphism in X-ray repair cross-complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. Cancer Res 2002;62:4630-6.
50. Nelson HH, Kelsey KT, Mott LA, Karagas MR. The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene-environment interaction. Cancer Res 2002;62:152-5.
51. Matullo G, Guarrera S, Sacerdote C, Polidoro S, Davico L, Gamberini S, et al. Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study. Cancer Epidemiol Biomarkers Prev 2005;14:2569-78.
52. Sturgis EM, Zheng R, Li L, Castillo EJ, Eicher SA, Chen M, et al. XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis 2000;21:2219-23.
53. Rybicki BA, Conti DV, Moreira A, Cicek M, Casey G, Witte JS. DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2004;13:23-9.
54. Huang WY, Chow WH, Rothman N, Lissowska J, Llaca V, Yeager M, et al. Selected DNA repair polymorphisms and gastric cancer in Poland. Carcinogenesis 2005;26:1354-9.
55. Shen H, Xu Y, Qian Y, Yu R, Qin Y, Zhou L, et al. Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int J Cancer 2000;88:601-6.
56. Bernardini S, Melino G, Cortese C, Ballerini S, Annicchiarico-Petruzzelli M, Bernassola F, et al. Modulation of glutathione transferase P1-1 activity by retinoic acid in neuroblastoma cells. J Cell Biochem 1999;75:375-81.
57. Sundberg K, Johansson AS, Stenberg G, Widersten M, Seidel A, Mannervik B, et al. Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis 1998;19:433-6.
58. Sundberg K, Seidel A, Mannervik B, Jernstrom B. Detoxication of carcinogenic fjord-region diol epoxides of polycyclic aromatic hydrocarbons by glutathione transferase P1-1 variants and glutathione. FEBS Lett 1998;438:206-10.
59. Hu X, Ji X, Srivastava SK, Xia H, Awasthi S, Nanduri B, et al. Mechanism of differential catalytic efficiency of two polymorphic forms of human glutathione S-transferase P1-1 in the glutathione conjugation of carcinogenic diol epoxide of chrysene. Arch Biochem Biophys 1997;345:32-8.
60. Hong SH, Kim JW, Kim HG, Park IK, Ryoo JW, Lee CH, et al. Glutathione S-transferases (GSTM1, GSTT1 and GSTP1) and N-acetyltransferase 2 polymorphisms and the risk of gastric cancer. J Prev Med Pub Health 2006; 39:135-40.
61. Palli D, Saieva C, Gemma S, Masala G, Gomez-Miguel MJ, Luzzi I, et al. GSTT1 and GSTM1 gene polymorphisms and gastric cancer in a high-risk Italian population. Int J Cancer 2005;115:284-9.
62. Colombo J, Rossit AR, Caetano A, Borim AA, Wornrath D, Silva AE. GSTT1, GSTM1 and CYP2E1 genetic polymorphisms in gastric cancer and chronic gastritis in a Brazilian population. World J Gastroenterol 2004;10:1240-5.
63. Setiawan VW, Zhang ZF, Yu GP, Li YL, Lu ML, Tsai CJ, et al. GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: a case-control study in a Chinese population. Cancer Epidemiol Biomarkers Prev 2000;9:73-80.
64. Martinez C, Martin F, Fernandez JM, Garcia-Martin E, Sastre J, Diaz-Rubio M, et al. Glutathione S-transferases mu1, theta1, pi1, alpha1 and mu3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans. Pharmacogenomics 2006;7:711-8.
65. Mannervik B, Danielson UH. Glutathione transferases - structure and catalytic activity. CRC Crit Rev Biochem 1988;23:283-337.
66. Thier R, Taylor JB, Pemble SE, Humphreys WG, Persmark M, Ketterer B, et al. Expression of mammalian glutathione S-transferase 5-5 in Salmonella typhimurium TA1535 leads to base-pair mutations upon exposure to dihalomethanes. Proc Natl Acad Sci USA 1993;90:8576-80.